-
Stomach Cancer Treatment Market Size, Share & Industry Analysis, By Drug Type (Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, and Others), By Disease Indication (Gastric Adenocarcinoma, Gastrointestinal Stromal Tumor (GIST)), By Route of Administration (Oral and Parenteral) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Regional Forecast, 2019-2032
The global stomach cancer treatment market size was valued at USD 2.61 billion in 2018 and is projected to reach USD 20.92 billion by 2032, exhibiting a CAGR of 16.0... Read More
Industries Expertise
Our Clients
